# PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer

> **NCT05103007** · NA · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** DEB-TACE
- **PROCEDURE:** PVL/PVE+DEB-TACE

## Key facts

- **NCT ID:** NCT05103007
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103007, "PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05103007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*